Literature DB >> 2059079

Cytidine deaminase activity, C reactive protein, histidine, and erythrocyte sedimentation rate as measures of disease activity in psoriatic arthritis.

P S Helliwell1, A Marchesoni, M Peters, R Platt, V Wright.   

Abstract

Cytidine deaminase activity, C reactive protein, histidine, and erythrocyte sedimentation rate were measured in 36 subjects with psoriatic arthritis of varying disease duration and severity. Although cytidine deaminase activity may provide an integrated measure of synovial inflammation in rheumatoid arthritis, neutrophil accumulation in psoriatic plaques compromises this measure in psoriatic arthritis. Low histidine concentrations confirm that this amino acid provides a non-specific index of synovial inflammation. In psoriatic arthritis high C reactive protein concentrations seem to be associated with extensive joint destruction. In this study the erythrocyte sedimentation rate was found to be the best laboratory guide to clinical disease activity in psoriatic arthritis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2059079      PMCID: PMC1004437          DOI: 10.1136/ard.50.6.362

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  7 in total

Review 1.  Psoriatic arthritis.

Authors:  J M Moll; V Wright
Journal:  Semin Arthritis Rheum       Date:  1973       Impact factor: 5.532

2.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

3.  Laboratory markers of joint inflammation and damage.

Authors:  P W Thompson
Journal:  Br J Rheumatol       Date:  1987-04

4.  Specificity of a low free serum histidine concentration for rheumatoid arthritis.

Authors:  D A Gerber; M G Gerber
Journal:  J Chronic Dis       Date:  1977-02

5.  The estimation of serum guanosine deaminase activity in liver disease.

Authors:  D D Jones; E L Roberts; A G Davies
Journal:  J Clin Chem Clin Biochem       Date:  1983-12

6.  Low free serum histidine concentration in rheumatoid arthritis. A measure of disease activity.

Authors:  D A Gerber
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

7.  Cytidine deaminase activity as a measure of acute inflammation in rheumatoid arthritis.

Authors:  P W Thompson; D D Jones; H L Currey
Journal:  Ann Rheum Dis       Date:  1986-01       Impact factor: 19.103

  7 in total
  5 in total

Review 1.  Metabolic disorders in patients with psoriasis and psoriatic arthritis.

Authors:  Lotus Mallbris; Christopher T Ritchlin; Mona Ståhle
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 2.  [Psoriatic arthritis : a permanent challenge for rheumatologists and patients--Part 1: epidemiology, pathogenesis and clinical course].

Authors:  S Finzel; M Englbrecht
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

Review 3.  Outcome measures in psoriatic arthritis clinical trials.

Authors:  Soumya M Reddy; Clifton O Bingham III
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

4.  Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumours.

Authors:  R Cohen; L H Preta; V Joste; E Curis; O Huillard; A Jouinot; C Narjoz; A Thomas-Schoemann; A Bellesoeur; M Tiako Meyo; J Quilichini; D Desaulle; I Nicolis; A Cessot; M Vidal; F Goldwasser; J Alexandre; B Blanchet
Journal:  Br J Clin Pharmacol       Date:  2019-01-30       Impact factor: 4.335

5.  Cytidine deaminase activity increases in the blood of breast cancer patients.

Authors:  Géraldine Buhagiar-Labarchède; Rosine Onclercq-Delic; Sophie Vacher; Frédérique Berger; Ivan Bièche; Dominique Stoppa-Lyonnet; Mounira Amor-Guéret
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.